Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Quantum Genomics

Quantum Genomics
2006 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
ALQGC STOCK SYMBOL
1 INVESTMENTS
$3.46 SHARE PRICE (As of Friday Closing)
Description

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure and heart failure.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Other Industries
Hospitals/Inpatient Services
Stock Exchange
PAR
Primary Office
  • 33 rue Marbeuf
  • 75008 Paris
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Quantum Genomics’s full profile, request a free trial.

Quantum Genomics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.72 - $8.54 $59.3M $3.50 -$0.53 159K 17.1M

Quantum Genomics Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 77,933 63,677 32,792 50,573
EBITDA (13,697) (15,914) (11,680) (6,867)
Net Income (11,305) (14,149) (10,580) (5,798)
Total Assets 18,853 21,140 16,696 15,261
Total Debt 1 3 1 1
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Quantum Genomics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Quantum Genomics‘s full profile, request access.

Request full access to PitchBook

Quantum Genomics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 29-Oct-2007 000000000000000000 Consulting Services (B2B) 000000 0é0000
To view this company’s complete investment and acquisition history, request access »

Quantum Genomics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 29-Oct-2007 000000000000000000 Completed
  • 0000000 00000000
To view this company’s complete exits history, request access »

Quantum Genomics Executive Team (6)

Name Title Board
Seat
Contact
Info
Jean-Philippe Milon Ph.D Chief Executive Officer
Marc Karako Chief Financial Officer, Director & Vice President, Finance
Maurice Salama Board Member & Managing Director of International Multifinance
Lionel Ségard Founder & Chairman
Bruno Besse Chief Medical Officer

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Quantum Genomics Board Members (4)

Name Representing Role Since Contact
Info
000000000 0é0000 Self Board Member 000 0000
000000 0é0000 Quantum Genomics Founder & Chairman 000 0000
0000 000000 Quantum Genomics Chief Financial Officer, Director & Vice President, Finance 000 0000
0000000 000000 Quantum Genomics Board Member & Managing Director of International Multifinance 000 0000